544 related articles for article (PubMed ID: 11395595)
41. Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome.
Gando S; Nakanishi Y; Tedo I
Crit Care Med; 1995 Nov; 23(11):1835-42. PubMed ID: 7587259
[TBL] [Abstract][Full Text] [Related]
42. [Levels of tissue-type plasminogen activator and plasminogen activator inhibitor 1 in disseminated intravascular coagulation syndrome].
Fukao H; Yamamoto K; Matsuo O
Rinsho Byori; 1991 Jul; 39(7):720-6. PubMed ID: 1920864
[TBL] [Abstract][Full Text] [Related]
43. Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease.
Brandtzaeg P; Joø GB; Brusletto B; Kierulf P
Thromb Res; 1990 Jan; 57(2):271-8. PubMed ID: 2315889
[TBL] [Abstract][Full Text] [Related]
44. Blood coagulation and fibrinolysis during normal pregnancy.
van Wersch JW; Ubachs JM
Eur J Clin Chem Clin Biochem; 1991 Jan; 29(1):45-50. PubMed ID: 1904779
[TBL] [Abstract][Full Text] [Related]
45. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.
Kario K; Matsuo T
Atherosclerosis; 1993 Nov; 103(2):131-8. PubMed ID: 8292090
[TBL] [Abstract][Full Text] [Related]
46. [Studies on molecular markers for hemostasis and thrombosis in various renal diseases].
Shibata T; Ishii T; Tomo T; Kaneko K; Nasu M; Magari Y; Fukushima K
Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):373-8. PubMed ID: 1831516
[TBL] [Abstract][Full Text] [Related]
47. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery.
Kojima T; Gando S; Morimoto Y; Mashio H; Goda Y; Kawahigashi H; Kemmotsu O
Thromb Res; 2001 Dec; 104(5):301-7. PubMed ID: 11738071
[TBL] [Abstract][Full Text] [Related]
48. [Peculiar increase of plasma plasminogen activator inhibitor 1 levels in patients with hemophagocytic histiocytosis].
Shimmyozu K; Kadokura N; Itoyama T; Tara M; Maruyama I; Osame M
Rinsho Ketsueki; 1990 Jan; 31(1):127-8. PubMed ID: 2313902
[TBL] [Abstract][Full Text] [Related]
49. Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas.
Hoshino M; Haraguchi Y; Hirasawa H; Sakai M; Saegusa H; Hayashi K; Horita N; Ohsawa H
Crit Care; 2001; 5(2):88-99. PubMed ID: 11299067
[TBL] [Abstract][Full Text] [Related]
50. The activation of neutrophil elastase-mediated fibrinolysis is not sufficient to overcome the fibrinolytic shutdown of disseminated intravascular coagulation associated with systemic inflammation.
Gando S; Hayakawa M; Sawamura A; Hoshino H; Oshiro A; Kubota N; Jesmin S
Thromb Res; 2007; 121(1):67-73. PubMed ID: 17397908
[TBL] [Abstract][Full Text] [Related]
51. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Shiku H
Thromb Haemost; 1995 Sep; 74(3):848-52. PubMed ID: 8571309
[TBL] [Abstract][Full Text] [Related]
52. Depressed plasma activity of plasminogen or alpha2 plasmin inhibitor is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation.
Asakura H; Ontachi Y; Mizutani T; Kato M; Ito T; Saito M; Morishita E; Yamazaki M; Suga Y; Miyamoto KI; Nakao S
Blood Coagul Fibrinolysis; 2001 Jun; 12(4):275-81. PubMed ID: 11460011
[TBL] [Abstract][Full Text] [Related]
53. Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study.
Koyama K; Madoiwa S; Nunomiya S; Koinuma T; Wada M; Sakata A; Ohmori T; Mimuro J; Sakata Y
Crit Care; 2014 Jan; 18(1):R13. PubMed ID: 24410881
[TBL] [Abstract][Full Text] [Related]
54. Diagnosis of disseminated intravascular coagulation by hemostatic molecular markers.
Wada H; Gabazza E; Nakasaki T; Shimura M; Hiyoyama K; Deguchi K; Nishikawa M; Sakuragawa N; Shiku H
Semin Thromb Hemost; 2000; 26(1):17-21. PubMed ID: 10805276
[TBL] [Abstract][Full Text] [Related]
55. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients.
Voves C; Wuillemin WA; Zeerleder S
Blood Coagul Fibrinolysis; 2006 Sep; 17(6):445-51. PubMed ID: 16905947
[TBL] [Abstract][Full Text] [Related]
56. Disseminated intravascular coagulation in transfusion-associated graft-versus-host disease. Report of two cases.
Murakawa M; Okamura T; Harada M; Esaki T; Kamura T; Shibuya T; Niho Y
Ann Clin Lab Sci; 1995; 25(1):31-8. PubMed ID: 7762966
[TBL] [Abstract][Full Text] [Related]
57. Increase in the D-dimer levels during treatment in patients with acute myelogenous leukemia.
Velasco F; Torres A; Rojas R; Alvarez MA; Gomez P; Castillo D
Haemostasis; 1992; 22(3):117-23. PubMed ID: 1427455
[TBL] [Abstract][Full Text] [Related]
58. [An analysis of DIC in patients with multiple organ failure--variations of the molecular makers and its clinical usefulness].
Gando S; Tedo I
Rinsho Ketsueki; 1990 Nov; 31(11):1774-9. PubMed ID: 2149574
[TBL] [Abstract][Full Text] [Related]
59. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio.
Kario K; Matsuo T; Kodama K; Matsuo M; Yamamoto K; Kobayashi H
Haemostasis; 1992; 22(4):179-86. PubMed ID: 1468720
[TBL] [Abstract][Full Text] [Related]
60. A prospective analysis of disseminated intravascular coagulation in patients with infections.
Seki Y; Wada H; Kawasugi K; Okamoto K; Uchiyama T; Kushimoto S; Hatada T; Matsumoto T; Imai H;
Intern Med; 2013; 52(17):1893-8. PubMed ID: 23994978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
